Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
Accenture (ACN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this consulting company have returned -6.8%, compared to the Zacks S&P 500 composite's +4.4% change. During this period, the Zacks Computers - IT Services industry, which Accenture falls in, has lost 0.4%. The key question now is: What could be the stock's future direction?Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.Accenture is expected to post earnings of $2.98 per share for the current quarter, representing a year-over-year change of +6.8%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.5%.For the current fiscal year, the consensus earnings estimate of $12.85 points to a change of +7.5% from the prior year. Over the last 30 days, this estimate has changed +1.5%.For the next fiscal year, the consensus earnings estimate of $13.63 indicates a change of +6.1% from what Accenture is expected to report a year ago. Over the past month, the estimate has changed +1.6%.Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Accenture is rated Zacks Rank #3 (Hold).The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:12 Month EPSRevenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.In the case of Accenture, the consensus sales estimate of $17.32 billion for the current quarter points to a year-over-year change of +5.6%. The $69.31 billion and $73.24 billion estimates for the current and next fiscal years indicate changes of +6.8% and +5.7%, respectively.Last Reported Results and Surprise HistoryAccenture reported revenues of $17.73 billion in the last reported quarter, representing a year-over-year change of +7.7%. EPS of $3.49 for the same period compares with $3.13 a year ago.Compared to the Zacks Consensus Estimate of $17.29 billion, the reported revenues represent a surprise of +2.56%. The EPS surprise was +5.76%.Over the last four quarters, Accenture surpassed consensus EPS estimates three times. The company topped consensus revenue estimates each time over this period.ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.Accenture is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Accenture. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.Higher. Faster. Sooner. Buy These Stocks NowA small number of stocks are primed for a breakout, and you have a chance to get in before they take off.At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.Download the report free now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Accenture PLC (ACN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Accenture
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Accenture
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Accenture plc
Analysen zu Accenture plc
Datum | Rating | Analyst | |
---|---|---|---|
20.09.2018 | Accenture Buy | Deutsche Bank AG | |
20.03.2018 | Accenture Outperform | Wedbush Morgan Securities Inc. | |
22.12.2017 | Accenture Buy | Pivotal Research Group | |
22.12.2017 | Accenture Equal Weight | Barclays Capital | |
22.12.2017 | Accenture Overweight | Cantor Fitzgerald |
Datum | Rating | Analyst | |
---|---|---|---|
20.09.2018 | Accenture Buy | Deutsche Bank AG | |
20.03.2018 | Accenture Outperform | Wedbush Morgan Securities Inc. | |
22.12.2017 | Accenture Buy | Pivotal Research Group | |
22.12.2017 | Accenture Overweight | Cantor Fitzgerald | |
08.11.2017 | Accenture Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
22.12.2017 | Accenture Equal Weight | Barclays Capital | |
27.09.2017 | Accenture Equal Weight | Barclays Capital | |
22.12.2016 | Accenture Equal Weight | Barclays Capital | |
30.09.2016 | Accenture Equal Weight | Barclays Capital | |
28.03.2016 | Accenture Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
19.12.2011 | Accenture sell | Société Générale Group S.A. (SG) | |
01.10.2010 | Accenture sell | Kaufman Bros., LP | |
26.08.2010 | Accenture sell | Kaufman Bros., LP | |
26.09.2006 | Update Accenture Ltd. : Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Accenture plc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen